Booz Allen’s Folly: A Comedy of Profits

Behold, gentle investors, Booz Allen Hamilton (BAH +7.52%), a name once whispered only in the shadowy corners of intelligence agencies – a consequence, if memory serves, of a former employee’s penchant for sharing secrets with the wider world. This morning, however, the company has burst forth onto the stage of public attention, not with intrigue, but with a most curious display of financial acrobatics, sending its shares soaring a full 9.2% by mid-morning. A spectacle, indeed!

The prognosticators, those learned soothsayers of the market, had predicted a modest earnings of $1.27 per share, upon revenues of $2.7 billion for the quarter. Booz Allen, alas, stumbled somewhat on the revenue front, presenting a sum of only $2.6 billion. Yet, like a player miraculously recovering from a misstep, it triumphed in earnings, delivering a handsome $1.77 per share. A most unexpected turn of events!

The Third Act: A Decline and a Delay

The company reports a decline in sales of 10% for the quarter, though they attribute a portion of this – a full four percent – to delays caused by last year’s governmental impasse. A convenient explanation, one might suggest, as if the funds were merely held backstage, awaiting their cue to reappear. Presumably, these revenues are postponed, not lost, a distinction as delicate as a courtier’s bow.

More troubling, however, is the company’s book-to-bill ratio, a paltry 0.3. A ratio so meager suggests a future where new contracts are as rare as honest politicians. Near-term growth appears as elusive as a phantom, and further declines may well be in the script. Yet, the trailing-12-month ratio of 1.1 offers a glimmer of hope – perhaps this quarter was merely a momentary lapse, a single off-key note in an otherwise harmonious performance.

But let us not despair! Profits have risen, and earnings have grown by a respectable 7%. Even more pleasing, free cash flow has eclipsed reported net profit, reaching a robust $248 million – an increase of 85%! A delightful surprise, and one that should warm the hearts of even the most cynical observers.

The Question of Purchase: A Matter of Prudence

Booz Allen has lowered its forecasts for both revenue and free cash flow, a humbling admission. Still, management anticipates generating between $825 million and $900 million in free cash flow by year’s end. At the higher end, the stock is valued at approximately 14 times free cash flow; at the lower end, a touch above 15. A reasonable price, perhaps, but hardly a bargain.

For a steady government contracting business with a dividend yield of 2.3%, it is a price that merits consideration. A “hold” rating, I believe, is prudent. A “buy” recommendation? Perhaps, but only for those with a taste for the mildly diverting, rather than the truly spectacular.

2026-01-23 20:22

The Third Act: A Decline and a Delay

The Question of Purchase: A Matter of Prudence

Read More